Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

Mesoporous Nano-Magnesium Oxide for Drug Loading

The USPTO has published a patent application for a mesoporous nano-magnesium oxide material designed for drug loading. The application details the material's properties, including particle size and pore structure, and outlines a preparation method involving magnesium oxalate and CTAB.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Adagrasib Solid Pharmaceutical Compositions for Treating Cancer

The USPTO has published a new patent application (US20260083679A1) detailing solid pharmaceutical compositions containing adagrasib for treating cancer. The application, filed on December 3, 2025, includes methods for manufacturing these compositions and treating cancer.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Oral GLP-1 Compound Dosing Patent Application

The USPTO has published a patent application (US20260083678A1) related to oral dosing of GLP-1 compounds. The application was filed on December 3, 2025, by inventors Flemming S. Nielsen and Per Sauerberg, and relates to improved uses of GLP-1 peptides in oral therapy.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application: Solid Medicinal Forms with Stabilised Active Ingredient

The USPTO has published a new patent application (US20260083677A1) from Astellas Pharma Inc. The application describes solid medicinal forms containing active ingredients stabilized with specific drying agents, aiming for reduced moisture content. This is a new patent filing, not a regulatory rule or guidance.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent for Spray-Dried Amorphous Solid Dispersions Using Polyvinyl Alcohol

The USPTO has published a new patent application (US20260083676A1) detailing a method for preparing spray-dried amorphous solid dispersions of active pharmaceutical ingredients using polyvinyl alcohol. The application was filed on September 14, 2023, by inventors Lena Mueller, Laura Halstenberg, Thomas Kipping, and Nicole Di Gallo.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

High-Bioactivity Goat Colostrum Powder Preparation Method

The USPTO has published a patent application detailing a method for preparing a high-bioactivity goat colostrum composite freeze-dried powder. The invention focuses on enhancing the stability and survival rate of probiotics within the powder through encapsulation techniques.

Routine Guidance Pharmaceuticals
Favicon for changeflow.com

Oxazolidinone Liposome Compositions with Improved Storage Stability

The USPTO has published a new patent application from Akagera Medicines, Inc. detailing oxazolidinone liposome compositions designed for improved storage stability. The application, filed on December 2, 2025, describes methods for manufacturing and using these compositions.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Cannabis Products and Methods Patent Application

The USPTO has published a patent application (US20260083661A1) for cannabis-based products and methods, including lotions, soaps, perfumes, and teas. The application was filed on October 7, 2025, and lists Lawrence Lanier Long as the inventor.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

KAO CORPORATION patent for hair treatment agent

The USPTO has published a patent application by KAO CORPORATION for a hair treatment agent. The application, filed on May 31, 2023, details a specific formulation involving film-forming polymers and organopolysiloxanes.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Sunscreen Compositions and Methods of Use

The USPTO has published a patent application from Mary Kay Inc. detailing new sunscreen compositions designed to protect skin from UV radiation. The application describes specific formulations involving film formers and organic UV filters, along with methods of making and using these compositions.

Routine Guidance Pharmaceuticals

Showing 3401–3410 of 31,225 changes

1 339 340 341 342 343 3123

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.